A Comparison of Patch vs. Pill Estrogen Therapy on Testosterone Levels and Thyroid Tests in Menopausal Women

Completed · Phase 4

Conditions studied: Menopause

In brief

This study compares the effects of 12 weeks of treatment with transdermal versus oral estrogen therapy on testsoterone levels and thyroid tests in healthy, naturally menopausal women.

Key facts

Study ID

NCT00224094

Run by

Watson Pharmaceuticals

People needed

27

Starts

2002-01-01

Last updated by the study team

2012-10-15

Who can join

Age: 42 and older, up to 70. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Healthy
• Naturally menopausal women
• Aged 42-70 years
• Currently using combination estrogen-progestin replacement therapy

You may not qualify if…

• Women with contraindications to HRT use, including:Unexplained vaginal bleeding, liver disease, breast or endometrial cancer, venous thromboembolic events
• Thyroid disease
• Adrenal disease

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.